It's time to kill the patient COVID-19 tax

It's time to kill the patient COVID-19 tax
Illustration Credit: Greg Groesch/Washington Times

More than 30 million Americans are now unemployed. These folks need all the help our nation can offer. Yet, disturbingly, the Trump administration just finalized a rule that will dramatically spike pharmacy costs. 

The rule allows insurers to disregard manufacturer coupons when calculating patients’ out-of-pocket expenses. This will increase what patients must spend before their insurance kicks in, potentially making critical prescriptions too expensive to fill.

For many Americans, high out-of-pocket costs already drive many to skip needed medicines.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Sorry, but the ‘drugs from Canada’ don’t work

Sorry, but the ‘drugs from Canada’ don’t work

“Drugs from Canada” is a policy that won’t work. And a political soundbite that won’t die....  Read more

Product Failure Is Not Process Failure

Product Failure Is Not Process Failure

FDA be nimble. FDA be quick. FDA jump over the bureaucratic schtick....  Read more

The Future of U.S. Biopharmaceutical Innovation and Supply Chain Security Lies in the Abraham Accords Region

The Future of U.S. Biopharmaceutical Innovation and Supply Chain Security Lies in the Abraham Accords Region

Congress must enact legislation that pushes our country forward, builds bridges where there are gaps, and leverages strat...  Read more

DRUGWONKS BLOG